Overview

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Status:
Suspended
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the side effects and how well high-dose brachytherapy works in treating patients with prostate cancer that has not spread to other parts of the body. Brachytherapy is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor and may be a better treatment in patients with prostate cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
National Cancer Institute (NCI)
Treatments:
Bicalutamide
Goserelin
Leuprolide
Triptorelin Pamoate